Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix

ClinicalTrials.gov ID: NCT00264732

Public ClinicalTrials.gov record NCT00264732. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Amolimogene (ZYC101a) in the Treatment of High-Grade Cervical Intraepithelial Lesions (CIN 2/3) of the Uterine Cervix

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of amolimogene, in the treatment of patients with high-grade cervical intraepithelial lesions of the uterine cervix.

Study identification

NCT ID
NCT00264732
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Eisai Inc.
Industry
Enrollment
251 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
13 Years to 25 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2005 (Type not available)
Primary completion
May 2009 (Actual)
Completion
May 2009 (Actual)
Last update posted
May 29, 2013

2005 – 2009

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35205 —
Arizona Wellness Center for Women/Precision Trials, LLC Phoenix Arizona 85032 —
University of Arizona Tucson Arizona 85724 —
Arrowhead Regional Medical Center Colton California 92324 —
The Center for Advanced Research and Education, Inc. Palm Springs California 92262 —
Medical Center for Clinical Research San Diego California 92108 —
Physicians Research Options, LC Lakewood Colorado 80228 —
Visions Clinical Research Boynton Beach Florida 33472 —
University of Florida, Miami Miami Florida 33136 —
Physician Care Clinical Research Sarasota Florida 34239 —
Insignia Clinical Research Tampa Florida 33613 —
Comprehensive Clinical Trials LLC West Palm Beach Florida 33409 —
Medical College of Georgia, Department of Family Medicine Augusta Georgia 30912 —
Rosemark Women's Care Specialists Idaho Falls Idaho 83404 —
University of Minnesota Minneapolis Minnesota 55455 —
Centennial Hills OB-GYN Associaties North Las Vegas Nevada 89030 —
Southwest Clinical Research Albuquerque New Mexico 87102 —
Lyndhurst Gynecologic Associates Winston-Salem North Carolina 27103 —
The University of Oklahoma Health Sciences Center, Center for Research in Women's Health Oklahoma City Oklahoma 73104 —
Temple Center for Women's Health Philadelphia Pennsylvania 19140 —
Sarah Cannon Research Memphis Tennessee 38120 —
Michael Altenbern, MD Nashville Tennessee 33437 —
UT Southwestern Medical Center at Dallas Dallas Texas 75390 —
Physicians' Research Options Pleasant Grove Utah 84062 —
Physicians' Research Options, LLC Sandy City Utah 84070 —
Tidewater Clinical Research Virginia Beach Virginia 23456 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00264732, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2013 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00264732 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →